How to Strengthen Laboratory Safety Across Life Science Industries?
Discover key 2026 trends shaping laboratory safety, from biosafety updates to better glove selection and contamination control
CHOOSE YOUR COUNTRY / REGION
Cleanroom PPE is often specified, validated and purchased one product category at a time. Contamination risk doesn't work that way.
Garments, gloves, eye and face protection, footwear, and RABS & isolator glove systems are often selected as separate product categories, sometimes from different suppliers and for different reasons. That's manageable from a purchasing perspective. Inside a pharmaceutical or biopharmaceutical cleanroom, however, those products are worn together by the same operator, performing the same task, within the same contamination-control programme.
Ansell's Head-to-Toe approach starts from a different premise: PPE should be treated as a coordinated people-control within the Contamination Control Strategy (CCS), selected according to application, exposure risk, cleanroom classification and task criticality, rather than as unrelated product categories.
EU GMP Annex 1 supports this view. The European Commission's 2022 revision states that a CCS should define critical control points, assess the effectiveness of controls used to manage contamination risk, and consider personnel as one of the key elements of the strategy.
For QA, Microbiology and cleanroom teams, the practical question is simple:
Can you explain why every part of your cleanroom PPE is used, how it works with the rest of the system, and what role it plays within your CCS?
Each of gloves, garments, goggles, facemasks, overboots and RABS & isolator glove systems is a valid decision on its own. The challenge appears when those decisions are not connected through a common risk-based rationale.
Operators move, reach, inspect, intervene, transfer, disinfect and handle materials throughout a shift. Every action creates an opportunity for contamination to be introduced, transferred or controlled.
PPE sits directly at that interface. Garments help contain particles shed by the body. Gloves create a barrier at critical surfaces. Eye and face protection help reduce exposure and contamination transfer. RABS & isolator glove systems become the operator's direct interface with first-air.
Annex 1 identifies personnel as one of the key elements of the CCS and can be a significant source of potential contamination. within a cleanroom environment. PPE therefore becomes more than an entry requirement; it becomes an active people-control designed to help reduce contamination risk during routine and critical interventions.
At the same time, even the most advanced PPE cannot compensate for poor gowning practices, inadequate training or inconsistent operator behavior. PPE selection, operator competency and gowning procedures should therefore be considered together as part of the contamination-control strategy.
Real-World Example: When PPE Selection Isn't Connected to Risk
One pharmaceutical manufacturer operating a new RABS environment discovered that its existing glove system lacked FDA approval, Annex 1 documentation and the cleanroom compatibility required for sterile manufacturing. After moving to ISO Class 4-compatible BioClean™ GGL36NIT59 gloves and supporting validation documentation, contamination risks were reduced and validation time was cut by up to 50%.
Annex 1 links clothing, cleanroom grade, process risk, garment integrity and operator behavior. Gowning is treated as an active contamination control, not simply a formality before entering the cleanroom. For a closer look at gowning expectations and sterile PPE selection across cleanroom grades, read EU GMP Annex 1: Are You Dressed for the Part?
Selected and documented against the process, cleanroom grade and ISO 14644 classification, PPE can form part of a wider CCS through documented contamination-control and sterility-assurance practices. It may help address microbial and particulate contamination, chemical exposure and process disruption.
Requirements scale with the manufacturing environment. Grade A and B operations typically require a more comprehensive sterile gowning specification than Grade C or D areas, but the aim is not to use more PPE. It is to select and document the protection appropriate to the identified risk.
The goal is to demonstrate why each element is appropriate for the grade, task and contamination risk identified within the CCS.
The conversation shifts from:
"What PPE should we buy?"
to:
"What contamination risk are we controlling?"
| PPE Element | CCS Question |
|---|---|
| Task / Application | What process is being performed and what contamination risks exist? |
| Garments | Does the garment suit the cleanroom grade and gowning SOP? |
| Gloves | Are sterility, material, cuff compatibility and disinfection requirements appropriate for the task? |
| Eye & Face Protection | Does it provide the required coverage without affecting visibility or fit? |
| Overshoes / Overboots | Does it support movement between controlled environments and gowning zones? |
| RABS & Isolator Glove Systems | Have barrier-system requirements been fully assessed? |
| Documentation | Can the selection be justified through risk assessment, validation and change control documentation? |
Answering those questions first is what moves PPE from the storeroom into the CCS.
Head-to-Toe protection is not about wearing more PPE. It is about applying one consistent contamination-control logic to every PPE decision.
| Team | Benefit of a Head-to-Toe PPE Approach |
|---|---|
| Quality Assurance (QA) | Clearer, more defensible contamination-control rationale |
| Validation | Supports qualification, documentation, and evidence gathering |
| Change Control | Structured framework for evaluating PPE modifications and supplier changes |
| Production | Standardization and consistency across operators, shifts, and sites |
Real-World Example: Managing Personnel-Related Contamination Risks
A global biopharmaceutical manufacturer experienced operator allergy concerns linked to latex gloves, alongside concerns about contamination from latex particles and proteins. After transitioning to sterile latex-free glove systems, allergy-related issues were no longer reported, workforce attendance and consistency improved, and contamination risks associated with latex particles were reduced. The site also supported its sustainability objectives through reduced packaging waste.
For Procurement teams, it can help reduce unnecessary supplier and SKU complexity while maintaining a risk-based approach to protection.
Together, these benefits turn PPE from a set of separate purchases into a coordinated programme linked to classification, task and risk.
Beyond individual products, Ansell Head-to-Toe Solutions are designed to support PPE assessment, selection, standardization, validation, implementation and lifecycle management through a coordinated protection strategy.
Head-to-Toe Solutions are built to support:
Head-to-Toe protection puts the contamination-control rationale on record at the personnel level: which PPE, for which task, against which risk.
Cleanroom PPE may be sourced by individual product category but it is used as one system by the operator. A Head-to-Toe approach helps connect each PPE decision to room classification, task risk, operator protection and the contamination-control objectives defined within the CCS.
It does not replace the CCS or guarantee Annex 1 compliance. It supports a more coordinated, documented and risk-based rationale for selecting and managing cleanroom PPE.
Ask your team one question: can they explain why every element is used and how it works with the rest of the system? If the answer isn't clear, that's where to start.
For more on how PPE, training, validation and documentation work together within a living CCS, read guide to strengthening cleanroom CCS alignment with Annex 1.
Contamination control starts with every part because every part plays a role.
One partner. One portfolio. One Head-to-Toe approach.